Prosecution Insights
Last updated: November 10, 2026

BLOOD IMAGE TECHNOLOGY LLC

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Analysis

BLOOD IMAGE TECHNOLOGY LLC currently manages 1 pending office action within the Medical Devices & Mechanical Engineering technology area. The prosecution landscape for this company features 1 distinct examiner and 1 distinct art unit. This structure shows that the company's current patenting efforts are focused on a specific technical domain under a single administrative review.

The busiest examiner for this portfolio is LE, QUYNH DAO, who is currently handling 1 busiest examiner pending office action. Because there is only 1 distinct examiner for the entire portfolio, LE, QUYNH DAO is responsible for all of the company's pending actions. This concentration means that the company's current patent outcomes are dependent on the decisions of this examiner.

The involvement of 1 distinct art unit indicates that the technical subject matter is being evaluated by one specialized group. With 1 pending office action total, the company's current active docket is small and focused. Practitioners should focus on the specific requirements of the 1 distinct examiner to advance the company's current patent applications.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LE, QUYNH DAO 1 33.3% +12.1%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17814538 CASSETTE APPARATUS FOR PROCESSING OF BLOOD TO NEUTRALIZE PATHOGEN CELLS THEREIN LE, QUYNH DAO 19d overdue

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17814538 CASSETTE APPARATUS FOR PROCESSING OF BLOOD TO NEUTRALIZE PATHOGEN CELLS THEREIN LE, QUYNH DAO 19d overdue

Top Art Units

Art UnitApps
3781 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17814538 CASSETTE APPARATUS FOR PROCESSING OF BLOOD TO NEUTRALIZE PATHOGEN CELLS THEREIN LE, QUYNH DAO 3781 §102§103 Final Rejection 19d overdue Pending Jul 25, 2022

Managing BLOOD IMAGE TECHNOLOGY LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does BLOOD IMAGE TECHNOLOGY LLC have?

BLOOD IMAGE TECHNOLOGY LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most BLOOD IMAGE TECHNOLOGY LLC applications?

Quynh Dao Le has the most, with 1 of BLOOD IMAGE TECHNOLOGY LLC's pending office actions.

What technology area are BLOOD IMAGE TECHNOLOGY LLC's patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month